Growth Metrics

BioCorRx (BICX) Share-based Compensation (2016 - 2025)

BioCorRx (BICX) has disclosed Share-based Compensation for 13 consecutive years, with $351258.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 23.02% to $351258.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $549290.0 through Dec 2025, up 1.09% year-over-year, with the annual reading at $592604.0 for FY2025, 51.4% down from the prior year.
  • Share-based Compensation hit $351258.0 in Q4 2025 for BioCorRx, up from $16060.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $351258.0 in Q4 2025 to a low of -$157625.0 in Q4 2021.
  • Historically, Share-based Compensation has averaged $68134.6 across 5 years, with a median of $29261.0 in 2024.
  • Biggest five-year swings in Share-based Compensation: tumbled 261.16% in 2021 and later skyrocketed 1132.27% in 2024.
  • Year by year, Share-based Compensation stood at -$157625.0 in 2021, then soared by 112.29% to $19376.0 in 2022, then soared by 97.48% to $38263.0 in 2023, then skyrocketed by 646.24% to $285533.0 in 2024, then grew by 23.02% to $351258.0 in 2025.
  • Business Quant data shows Share-based Compensation for BICX at $351258.0 in Q4 2025, $16060.0 in Q3 2025, and $30715.0 in Q2 2025.